AdAlta presents at TCN Emerging ASX Gems conference

AdAlta Limited (ASX: 1AD) CEO and Managing Director, Dr Tim Oldham presented at The Capital Network (TCN) Emerging ASX Gems investment conference livestream on 7 July 2023.

Dr Oldham’s presentation provides an introduction to, and an explanation of AdAlta’s powerful i-body discovery platform, and the next generation therapeutics in development or in the pipeline, to treat fibrotic disease, oncology and cellular immunotherapy.

Click below to hear an update on AdAlta’s pipeline programs. Dr Oldham highlights the enhanced partnering opportunity flowing from new data released on 7 July, that favourably links AD-214 preclinical animal studies and Phase I human trial results, supporting efficacy at clinically viable dose regimens.